Several studies have shown that CRC patients with negative expressions of IGF-1R and Livin had significantly higher accumulative survival rate and longer mean survival duration than those with positive expression of IGF-1R and Livin [18, 26, 31]. This evidence concerns the gene IGF1R and colorectal carcinoma.